Malaysia IVD In-Vitro Diagnostic Compliance: Classification and Registration for Rapid Tests, Pregnancy Tests and Glucose Meters

In-vitro diagnostic medical devices (In-Vitro Diagnostic, IVD) refer to reagents, calibrators, test kits and related instruments used to examine human specimens (blood, urine, saliva, etc.) to provide medical or diagnostic information. Under section 2 of the Medical Device Act 2012 (Act 737) and the MDA's definition, IVDs are medical devices, governed by the Medical Device Authority (MDA); section 5(1) provides that unregistered devices may not be imported, exported or sold on the market. The most common everyday items — pregnancy test kits, glucose meters, cholesterol test strips, COVID-19 rapid tests, and even laboratory HIV and hepatitis tests — all fall within the IVD scope. For the overall registration system, see the full MDA medical device registration process first.

IVDs have their own classification

The risk classification of IVDs is different from the classification rules for general medical devices; the MDA sets a separate four-tier A–D scale, distinguished by the degree of impact of the test result on the individual and on public health. A key point to note: for the same test item, if it is designed for "self-testing by the general public at home (self-test)" rather than operated by trained laboratory personnel, the risk grade is usually upgraded — because the consequences of a misreading are more serious. Another often-overlooked detail: an analyser and its dedicated reagents and test kits are often classified and registered separately according to their respective uses, so you cannot assume that buying one instrument covers all consumables at once. For the overall logic of grade determination, see the further reading on medical device risk classification.

Registration process

1. Confirm the classification: define A/B/C/D under the MDA IVD classification guidance.
2. Conformity assessment (CAB): Class B, C and D must first be reviewed by a designated CAB; Class A can be submitted directly.
3. Licensed establishment: the manufacturer/importer/agent must hold an Establishment Licence; an overseas manufacturer must appoint a local authorised representative (AR) — see the authorised representative system.
4. Online submission: submit the registration through the MDA online system, and only after approval and obtaining a registration number may the product go to market.

Special notes on rapid tests / self-tests

Rapid tests and home self-test products operated by the public, besides usually being at a higher risk grade, also carry stricter labelling and instruction requirements: there must be clear, easy-to-understand operating steps in the local language (English/Malay), the reading method, and recommendations for follow-up handling of results, plus the registration number, lot number, expiry date and storage conditions. The self-test reagents during the COVID-19 period were regulated and vetted by the MDA, highlighting the public-health sensitivity of self-test IVDs.

Import and post-market

A company importing IVDs must be an MDA-licensed establishment, while an overseas manufacturer completes registration and the attribution of market responsibility through a local authorised representative. Post-market, there are continuing obligations: re-registration must be arranged before the registration validity expires; major changes such as reagent formulation, reading thresholds or packaging specifications must be reported under the variation procedure; and if adverse events such as misreadings or quality defects occur, they must be reported under the MDA's post-market surveillance requirements, with a recall initiated where necessary. Because IVDs involve diagnostic accuracy, the competent authority pays particular attention to the traceability of their lot numbers and the labelling of storage conditions.

Labelling and common mistakes

• Selling a product as an ordinary health/testing gadget without confirming it is an IVD.
• Self-test products carrying over the professional-version classification, underestimating the risk grade that should be upgraded.
• The importer not holding an establishment licence, or listing rapid tests before completing registration.
• The label missing the registration number, lot number, expiry date or local-language instructions.

Frequently asked questions (FAQ)

Q: Do pregnancy test kits and glucose meters also need MDA registration? Yes. Both are IVD medical devices: pregnancy self-test is generally Class B and glucose self-test generally Class C, and they must be registered to be sold lawfully.

Q: Is IVD classification the same as for general medical devices? No. IVDs have their own dedicated A–D risk classification rules, distinguished by the test's impact on the individual and public health; the exact grade is subject to the MDA IVD classification guidance and the CAB determination.

Q: Why is the "self-test" version a higher risk grade? Because it is operated by untrained members of the public, and the consequences of a misreading or mishandling are more serious, the MDA usually upgrades the risk grade of the self-test version relative to the professional version.

Q: What qualifications are needed to import rapid test reagents? The importer must hold an MDA establishment licence and the product must be registered; an overseas manufacturer must appoint a licensed local authorised representative to act on its behalf, and Class B and above must first pass CAB assessment.

Q: What class is an HIV test? HIV blood diagnosis and blood-donation screening are the highest-risk Class D, the most tightly regulated, involving blood safety and major public-health risk.

Self-check checklist

• [ ] Confirmed the product is an IVD and set A/B/C/D under the MDA IVD rules
• [ ] Reviewed whether the self-test version needs an upgraded risk grade
• [ ] Class B/C/D have completed CAB conformity assessment
• [ ] The importer holds an establishment licence, and the overseas plant has appointed a local AR
• [ ] The label includes the registration number, lot number, expiry date and local-language instructions

Summary: Pregnancy, glucose, rapid and HIV tests are all IVDs, governed under Act 737 with a dedicated A–D classification; self-test products are especially sensitive, with higher risk grades and stricter labelling requirements. The compliance sequence is: set the classification, pass the CAB, register through a licensed establishment, and get the labelling in place.

Run a free label check now

This article is compiled from official sources for reference only; actual compliance is subject to the latest official text and review by the competent authority.